Sequenta
About:
Sequenta is engaged in the discovery and development of clinical diagnostics based on a platform for understanding immune system status.
Website: http://www.sequenta.com/
Twitter/X: SequentaInc
Top Investors: Foresite Capital, Index Ventures, Mohr Davidow Ventures, Celgene, Farzad Nazem
Description:
Sequenta is a venture funded biotech company dedicated to the discovery and development of clinical diagnostics based on a revolutionary new platform for understanding immune system status. A profound revolution in the cost of DNA sequencing has enabled the company to develop brand new approaches to measuring the most variable part of the human genome: the immune cell receptor genes. The incredible diversity created by these genes are at the heart of a large number of conditions critical to human health and disease allowing the company to be in a position to inform a large number of clinical decisions using a single powerful assay. The company was founded in 2008 by entrepreneurs who previously founded ParaAllele BioScience, a successful startup company sold to Affymetrix in 2005.
$43.5M
$1M to $10M
San Francisco, California, United States
2008-01-01
tom.willis(AT)mlcdx.com
Malek Faham, Tom Willis
51-100
2014-10-20
Private
© 2025 bioDAO.ai